Ranitidine hydrochloride

Cat. No.: OB0225LY-0100

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR and LC-MS.

Size:

INQUIRY Datasheet MSDS

Product Overview

Description: Ranitidine hydrochloride is an H2 receptor antagonist used to reduce gastric acid secretion. Its salt form, hydrochloride, is its usual dosage form.

Synonym: AH19065; 66357-59-3; 1,1-Ethenediamine, N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-; 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-; (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-n'-methyl-2-nitro-1,1-ethenediamine

CAS No.: 66357-59-3

Compound CID: 3001055

Formula: C₁₃H₂₃ClN₄O₃S

Formula Weight: 350.86

Specification

Relative Density: 1.044 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Ranitidine hydrochloride is Mainly used to study the treatment of gastroesophageal reflux disease (GERD), peptic ulcer, and prevention of recurrence of gastric acid-related diseases.